ENOV
NYSEEnovis CORP
Technology · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
🔒 price chart needs market-data feed$1.4B
2021
$1.6B
2022
$1.7B
2023
$2.1B
2024
$2.2B
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$2.2B
Net Income$-1.2B
Gross Profit$1.3B
Oper Income$-1.1B
EPS (dil)$-20.75
Rev/sh$39.05
FCF/sh$0.35
Book/sh$25.92
Gross M59.8%
Oper M-50.0%
Profit M-52.7%
FCF M0.9%
ROE-79.3%
ROA-30.9%
ROIC-41.1%
R&D/Rev5.4%
Rev Y/Y6.7%
Rev 3Y CAGR12.9%
EPS Y/Y-39.0%
EPS 3Y CAGR—
FCF 3Y CAGR—
Payout0%
Div/sh—
Shs Chg Y/Y+3.2%
Current Ratio2.02
Quick Ratio1.04
Debt/Eq0.89
Int Coverage-32.3×
Net Debt$1.3B
Total Debt$1.3B
Cash & Eq$36.4M
Total Assets$3.8B
Oper CF$217.3M
Capex$197.4M
Free CF$19.9M
Buybacks$3.5M
Equity$1.5B
Liabilities$2.3B
Shs Outstand0.06B
SectorTechnology
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.6B | $1.7B | $2.1B | $2.2B |
| Gross Profit | $777.7M | $869.4M | $990.8M | $1.2B | $1.3B |
| Operating Income | $-62.8M | $-71.2M | $-65.7M | $-775.7M | $-1.1B |
| Net Income | $76.3M | $-11.8M | $-32.7M | $-824.8M | $-1.2B |
| Diluted EPS | $1.40 | $-0.25 | $-0.61 | $-14.93 | $-20.75 |
| Operating Cash Flow | $356.1M | $-55.9M | $135.0M | $113.5M | $217.3M |
| Free Cash Flow | $251.9M | $-161.3M | $12.8M | $-67.2M | $19.9M |
COMMUNITY · $ENOV0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.